The SpiroSonic Ultrasonic spirometer uses high fidelity multi-path ultrasound for pulmonary function testing.The SpiroSonic Suite features user-friendly digital respiratory devices providing research quality spirometry at affordable costs. Based on ultrasonic flow measurements and ultrasonic spirometry, each product is the result of years of research, technological development and innovation. USCOM is a platform technology providing non-invasive methods of monitoring heart function. The company was founded by its current CEO, Mr Rob Phillips. The company's first patents were filed in June of 1998 with Uscom Inc being formed in 2006. The Uscom Sydney office opened in August of 2002. Uscom Ltd is an Australian medical device company focused on non-invasive, high fidelity measurement of cardiovascular function. These measurements can be used to assess and manage hemodynamics. Optimizing circulation saves lives. USCOM provides for safe, rapid, accurate and cost effective optimization of circulation. USCOM takes advanced hemodynamics beyond the ICU. The first USCOM 1A device was completed in October 2002 and Uscom listed on the Australian Stock Exchange in December of 2003.